ALLMedicine™ Band Keratopathy Center

Feb 25th, 2023 - Pierson syndrome is a rare autosomal recessive disorder that causes congenital nephrotic syndrome, neurodevelopmental abnormalities, and several ocular signs. The Pierson syndrome is caused by a mutation of the LAMB2 gene, that encodes laminin bet...

Feb 6th, 2023 - Background Intermediate uveitis refers to inflammation localized to the vitreous and peripheral retina. [1] Intermediate uveitis was first described in the literature as chronic cyclitis by Fuchs in 1908. According to the Standardization of Uveiti...

Feb 6th, 2023 - Background Intermediate uveitis refers to inflammation localized to the vitreous and peripheral retina. [1] Intermediate uveitis was first described in the literature as chronic cyclitis by Fuchs in 1908. According to the Standardization of Uveiti...

Feb 6th, 2023 - Background Intermediate uveitis refers to inflammation localized to the vitreous and peripheral retina.[1] Intermediate uveitis was first described in the literature as chronic cyclitis by Fuchs in 1908. According to the Standardization of Uveitis...

Jan 13th, 2023 - Background Band keratopathy is characterized by the appearance of an opaque white band of variable density across the central cornea, caused by the precipitation of calcium salts, primarily hydroxyapatite, on the underside of the corneal epitheliu...

Jan 5th, 2022 - This study is an open-label, pilot study of up to 6 subjects with documented BK. This study has 2 phases: In Phase 1 subjects must be willing to return to the clinic for evaluation of safety and BK symptoms during the treatment period of 6 months ...

Dec 28th, 2021 - Although non-infectious uveitis is rare in pediatric population, the irreversible visual impairment due to ocular complications, severe drug adverse effects are disturbing. There is a high rate of chronic disorder of ocular inflammation and unresp...

Dec 21st, 2017 - 20% of patients with juvenile idiopathic arthritis (JIA) develop usually bilateral, chronic anterior uveitis, dependent on steroid eye drops and sometimes systemic steroid therapy, with a risk of complications such as cataract, band keratopathy an...

Apr 4th, 2018 - Action Points Note that an expert panel has created guidelines for the diagnosis and management of uveitis in patients with JIA characterized by the need for early, and potentially frequent, screening. Be aware that the recommendations are only ra...

May 8th, 2013 - NEW YORK – Tailoring the frequency of vision screening for children with juvenile idiopathic arthritis is an important step to getting uveitis symptoms treated effectively before permanent morbidity occurs, according to Dr. Sanjay R.

Mar 1st, 2011 - SNOWMASS, COLO. – Abatacept may be a safe and effective therapy for patients with juvenile idiopathic arthritis and severe uveitis that is refractory to anti–tumor necrosis factor agents.

Feb 16th, 2011 - SNOWMASS, COLO. – Abatacept may be a safe and effective therapy for patients with juvenile idiopathic arthritis and severe uveitis that is refractory to anti–tumor necrosis factor agents.

Feb 16th, 2011 - SNOWMASS, COLO. – Abatacept may be a safe and effective therapy for patients with juvenile idiopathic arthritis and severe uveitis that is refractory to anti–tumor necrosis factor agents.